Under the collaboration and license agreement, Abbott will lead the development and commercialization of monoclonal antibodies targeting the cMet receptor. Pierre Fabre will receive an initial $25m upfront
The acquisition expands Thermo Fisher’s portfolio of reagents and other consumables for the molecular biology research and diagnostics markets through the addition of its proprietary DNA polymerases, Phire
The company claims that Juvederm is the first and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment. Juvederm
Kyowa Hakko Kirin will be responsible for the approval process for the product in Japan. Under the terms of the agreement, KW-2246 will be jointly distributed by the
Rio Tinto had announced on August 18, 2009, the receipt of a binding offer from Amcor for these businesses for a total consideration of $2.02b. The completion of
Reportedly, Ecoheart chewable tablets is the first animal product for which the company has received a marketing authorisation in Latin America. Further marketing authorisations in the key markets
Under the terms of the agreement, Therapure will be responsible for the manufacture of two major plasma proteins and LFB will remain responsible for global regulatory approvals and
Eric Schmidhaeuser, managing director of Schorndorf operation, said: “We believe the addition of this new potent handling and over-encapsulation area will help to meet the needs of our
COP (Cyclic Olefin Polymer) is a heavy-metal-free plastic that Gerresheimer has also used for sterile syringes over many years. It has specific advantages which makes it particularly suitable
It has been identified to be effective on anaerobes, aerobes and protozoa that cause diarrhea, dysentery, enteritis, traveler’s diarrhea and acute food poisoning. Mebatic Infusion has shown 20-25%
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.